Psychedelic Spotlight
  • News
  • Culture
  • Business
    • Business
    • News
    • Editorial
    • Stock Reports
    • Videos
    • Interviews
  • Research
  • Policy
  • Media
    • Podcast
    • Videos
  • Work With us
    • Work With Us
    • Contact Us
    • About
  • Media Kit
  • Bonfire Community
    • Work with us
  • Search
  • Menu Menu
Home1 / Psychedelic Spotlight News2 / Business3 / Videos4

PSY: The First American Psychedelic ETF [Excerpt]

byPsychedelic SpotlightonJune 13, 2021
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn

Since Last week's episode was so long, we decided to cut it into pieces so we don't bore you guys!
The ETF “seeks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index, a rules-based index that tracks the performance of companies listed in North American Exchanges that operate business models focused on the legal usage of psychedelics, cannabis, and ketamine for therapeutic purposes.”
In this excerpt, we cover what the new American psychedelic ETF (PSY:NYSE) is, as well as my thoughts on it!

Enjoy the mini episode!
Link:
https://www.defianceetfs.com/psy/

‘PSY' Becomes First U.S.-Listed Psychedelic ETF

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌

Instagram: @thepsychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Website: https://thepsychedelicinvestor.com/
Music: www.bensound.com
Video editing: @themyaholy
https://benzinga.grsm.io/jameshallifa…

https://benzinga.grsm.io/thepsychedel…

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #PSY #PsychedelicETF

Have you heard about our new community?

We’re excited to announce Bonfire -
a personal growth community
for people who are interested in psychedelics.

Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.

Sign Up Here

Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.

Explore

  • About
  • Treatment
  • Work With Us
  • News
  • Privacy Policy
  • Terms and Conditions

Resources

  • Conferences
  • Experts
  • Glossary
  • Therapy

Subscribe

           

© 2022 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.
MindMed To Deliver Psychedelics Directly To The Brain? (MMED / MNMD)Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion ValuationPeter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuati...
Scroll to top

Get a roundup of Psychedelic news stories in your inbox

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Hidden
Which list would you like to subscribe to?
Enter your email below to subscribe to Psychedelic News.